We feel that administration of this combination might have decreased the irritative, bronchospastic
effects of both FB and bronchoscope on tracheobronchial tree.
Patients having hypertension, bronchospastic
disease, cardiac problem, anticipated difficult airway and patients on beta blockers were excluded from the study.
This is seen in asthmatics, and in general propranolol will not be prescribed to a person who has bronchospastic
obstructive or Avoid in patients with renal bronchospastic
72 (1 patch) (8 doses) Oral Inhaler Bupropion SR Product Nicotrol Inhaler (3) Zyban (1), Generic Rx Rx 10 mg cartridge 150 mg sustained- delivers 4 mg inhaled release tablet nicotine vapor Precautions * Recent ([less than * Concomitant therapy or equal to] 2 with medications weeks) myocardial or medical infarction * conditions known to * Serious underlying lower the seizure arrhythmias threshold * Serious or worsening * Severe hepatic angina pectoris * cirrhosis * Bronchospastic
* Pregnancy disease * category: C * Pregnancy Contraindications: category: D * Seizure disorder * Concomitant bupropion (e.
I have used it sufficiently to know it is helpful for some patients with bronchospastic
and pulmonary obstructive.
Inhaler Local irritation, use with caution in people with bronchospastic
disease (slow inhalation lessens irritation).
Profile of bronchospastic
disease in Puerto Rican patients in New York City.
Proposed mechanisms for the paradoxical bronchospastic
effect of albuterol include bronchospasm secondary to other compounds in the albuterol preparations such as benzalkonium chloride (used as a preservative in nebulizer solutions), (5) chlorofluorocarbons (used as propellants in metered dose inhalers), (5) and oleic acid (used as a dispersant in MDIs), (5) and the presence of (S)-albuterol in racemic preparations of albuterol.
We were most interested in effects seen in the first few days after exposure that we felt were most likely to reflect inflammatory, as opposed to acute bronchospastic
, asthmatic changes.
Long-acting beta-2 adrenergic bronchodilators are used as maintenance medications taken daily on a scheduled basis to prevent acute bronchospastic
Rythmol SR is contraindicated for use in patients with medical conditions producing marked hypotension, disturbances in cardiac impulse generation or conduction, electrolyte imbalances, bronchospastic
disorders or hypersensitivity to the drug.